Mutation of H-ras is infrequent in bladder cancer : confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing

A series of 152 human bladder tumors, 14 bladder tumor cell lines, and 1 immortal urothelial cell line were examined by single-strand conformation polymorphism (SSCP) and designed restriction fragment.length polymorphism analyses for mutations in exons 1 and 2 of the H-ras gene. Nine tumors (6%) con...

Full description

Saved in:
Bibliographic Details
Published inCancer research (Chicago, Ill.) Vol. 53; no. 1; pp. 133 - 139
Main Authors KNOWLES, M. A, WILLIAMSON, M
Format Journal Article
LanguageEnglish
Published Philadelphia, PA American Association for Cancer Research 1993
Subjects
Online AccessGet full text
ISSN0008-5472

Cover

Abstract A series of 152 human bladder tumors, 14 bladder tumor cell lines, and 1 immortal urothelial cell line were examined by single-strand conformation polymorphism (SSCP) and designed restriction fragment.length polymorphism analyses for mutations in exons 1 and 2 of the H-ras gene. Nine tumors (6%) contained mutations. There was complete concordance between SSCP and restriction fragment length polymorphism analyses. Six mutations in exon 1 and three in exon 2 were identified by SSCP analysis. Subsequent restriction fragment length polymorphism analysis showed that of the exon 1 mutations, four were in codon 12 and two in codon 13, and all three exon 2 mutations were in codon 61. Eight mutations were confirmed by direct sequencing. One codon 13 mutation could not be identified by direct sequencing. Distinct strand mobility shifts detected by SSCP analysis identified specific point mutations, and in all cases, strands containing different mutations migrated differently. The base substitutions identified in these bladder tumors were diverse and included four transversions (three G-->T and one A-->T) and four transitions (two G-->A and two A-->G). This pattern of base substitutions is compatible with interactions of the urothelium with more than one class of environmental agent during bladder tumor development. No correlation was found between tumor grade and/or stage and the presence of H-ras mutation. We conclude that H-ras mutation does not play a role in the development of the majority of transitional cell tumors of the bladder.
AbstractList A series of 152 human bladder tumors, 14 bladder tumor cell lines, and 1 immortal urothelial cell line were examined by single-strand conformation polymorphism (SSCP) and designed restriction fragment.length polymorphism analyses for mutations in exons 1 and 2 of the H-ras gene. Nine tumors (6%) contained mutations. There was complete concordance between SSCP and restriction fragment length polymorphism analyses. Six mutations in exon 1 and three in exon 2 were identified by SSCP analysis. Subsequent restriction fragment length polymorphism analysis showed that of the exon 1 mutations, four were in codon 12 and two in codon 13, and all three exon 2 mutations were in codon 61. Eight mutations were confirmed by direct sequencing. One codon 13 mutation could not be identified by direct sequencing. Distinct strand mobility shifts detected by SSCP analysis identified specific point mutations, and in all cases, strands containing different mutations migrated differently. The base substitutions identified in these bladder tumors were diverse and included four transversions (three G-->T and one A-->T) and four transitions (two G-->A and two A-->G). This pattern of base substitutions is compatible with interactions of the urothelium with more than one class of environmental agent during bladder tumor development. No correlation was found between tumor grade and/or stage and the presence of H-ras mutation. We conclude that H-ras mutation does not play a role in the development of the majority of transitional cell tumors of the bladder.A series of 152 human bladder tumors, 14 bladder tumor cell lines, and 1 immortal urothelial cell line were examined by single-strand conformation polymorphism (SSCP) and designed restriction fragment.length polymorphism analyses for mutations in exons 1 and 2 of the H-ras gene. Nine tumors (6%) contained mutations. There was complete concordance between SSCP and restriction fragment length polymorphism analyses. Six mutations in exon 1 and three in exon 2 were identified by SSCP analysis. Subsequent restriction fragment length polymorphism analysis showed that of the exon 1 mutations, four were in codon 12 and two in codon 13, and all three exon 2 mutations were in codon 61. Eight mutations were confirmed by direct sequencing. One codon 13 mutation could not be identified by direct sequencing. Distinct strand mobility shifts detected by SSCP analysis identified specific point mutations, and in all cases, strands containing different mutations migrated differently. The base substitutions identified in these bladder tumors were diverse and included four transversions (three G-->T and one A-->T) and four transitions (two G-->A and two A-->G). This pattern of base substitutions is compatible with interactions of the urothelium with more than one class of environmental agent during bladder tumor development. No correlation was found between tumor grade and/or stage and the presence of H-ras mutation. We conclude that H-ras mutation does not play a role in the development of the majority of transitional cell tumors of the bladder.
A series of 152 human bladder tumors, 14 bladder tumor cell lines, and 1 immortal urothelial cell line were examined by single-strand conformation polymorphism (SSCP) and designed restriction fragment length polymorphism analyses for mutations in exons 1 and 2 of the H-ras gene. Nine tumors (6%) contained mutations. There was complete concordance between SSCP and restriction fragment length polymorphism analyses. Six mutations in exon 1 and three in exon 2 were identified by SSCP analysis. Subsequent restriction fragment length polymorphism analysis showed that of the exon 1 mutations, four were in codon 12 and two in codon 13, and all three exon 2 mutations were in codon 61. Eight mutations were confirmed by direct sequencing. One codon 13 mutation could not be identified by direct sequencing. Distinct strand mobility shifts detected by SSCP analysis identified specific point mutations, and in all cases, strands containing different mutations migrated differently. The base substitutions identified in these bladder tumors were diverse and included four transversions (three G arrow right T and one A arrow right T) and four transitions (two G arrow right A and two A arrow right G). No correlation was found between tumor grade and/or stage and the presence of H-ras mutation. We conclude that H-ras mutation does not play a role in the development of the majority of transitional cell tumors of the bladder.
A series of 152 human bladder tumors, 14 bladder tumor cell lines, and 1 immortal urothelial cell line were examined by single-strand conformation polymorphism (SSCP) and designed restriction fragment.length polymorphism analyses for mutations in exons 1 and 2 of the H-ras gene. Nine tumors (6%) contained mutations. There was complete concordance between SSCP and restriction fragment length polymorphism analyses. Six mutations in exon 1 and three in exon 2 were identified by SSCP analysis. Subsequent restriction fragment length polymorphism analysis showed that of the exon 1 mutations, four were in codon 12 and two in codon 13, and all three exon 2 mutations were in codon 61. Eight mutations were confirmed by direct sequencing. One codon 13 mutation could not be identified by direct sequencing. Distinct strand mobility shifts detected by SSCP analysis identified specific point mutations, and in all cases, strands containing different mutations migrated differently. The base substitutions identified in these bladder tumors were diverse and included four transversions (three G-->T and one A-->T) and four transitions (two G-->A and two A-->G). This pattern of base substitutions is compatible with interactions of the urothelium with more than one class of environmental agent during bladder tumor development. No correlation was found between tumor grade and/or stage and the presence of H-ras mutation. We conclude that H-ras mutation does not play a role in the development of the majority of transitional cell tumors of the bladder.
Author KNOWLES, M. A
WILLIAMSON, M
Author_xml – sequence: 1
  givenname: M. A
  surname: KNOWLES
  fullname: KNOWLES, M. A
  organization: Marie Curie res. inst., epithelial carcinogenesis lab., Oxted, Surrey RH8 0TL, United Kingdom
– sequence: 2
  givenname: M
  surname: WILLIAMSON
  fullname: WILLIAMSON, M
  organization: Marie Curie res. inst., epithelial carcinogenesis lab., Oxted, Surrey RH8 0TL, United Kingdom
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4478739$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/8093230$$D View this record in MEDLINE/PubMed
BookMark eNqFkctKxDAUhrtQdLw8gpCFuLKQNk2TupPBGyhudD2cJqedSJrUpLPo0_lqxnEUXAmBk8P__efP5Sjbc97hXraglMqcV6I8zI5ifEstLyg_yA4kbVjJ6CL7eNpMMBnviO_IfR4gEpOW6wK-b9BNaUtaC1pjIAqcSuWKKO86E4ZvXzuTaFxvMY9TAKe3qv9RR2_nwYdxbeJAwIGdo4mXRGM0vUNNAiaXUVu2C9APX5kWXT-t_3iT52u2NgHVROL2cCrFnmT7HdiIp7t6nL3e3rws7_PH57uH5fVjvi4bOeW6UVBIKriWwLUC7HRdCaRVVbcMm7qkqq0Zq4EVyNqulrIRAK3QssBGVMCOs4vvuWPwKTtOq8FEhdaCQ7-JK8F5SRvJ_wWLmouasyqBZztw0w6oV2MwA4R5tfuapJ_vdIgKbHqcdOH4i1WVkII17BOPNZ4K
CODEN CNREA8
ContentType Journal Article
Copyright 1993 INIST-CNRS
Copyright_xml – notice: 1993 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7T3
7TM
7TO
8FD
FR3
H94
P64
RC3
7X8
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Human Genome Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Human Genome Abstracts
Genetics Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
Nucleic Acids Abstracts
AIDS and Cancer Research Abstracts
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Human Genome Abstracts
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EndPage 139
ExternalDocumentID 8093230
4478739
Genre Journal Article
GroupedDBID ---
-ET
.55
.GJ
18M
29B
2WC
34G
39C
3O-
53G
5GY
5RE
5VS
6J9
8WZ
A6W
AAJMC
ABOCM
ACGFO
ACIWK
ACPRK
ACSVP
ADBBV
ADCOW
ADNWM
AENEX
AETEA
AFFNX
AFHIN
AFOSN
AFRAH
AFUMD
AI.
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
C1A
CS3
D0S
DIK
DU5
EBS
EJD
F5P
FRP
GX1
H13
IH2
IQODW
J5H
KQ8
L7B
LSO
MVM
OHT
OK1
P0W
P2P
PQQKQ
RCR
RHI
RNS
SJN
TR2
UDS
VH1
W2D
W8F
WH7
WHG
WOQ
X7M
XJT
YKV
YZZ
ZCG
ZGI
CGR
CUY
CVF
ECM
EIF
NPM
RHF
VXZ
7T3
7TM
7TO
8FD
AAFWJ
FR3
H94
P64
RC3
7X8
ID FETCH-LOGICAL-h298t-d9ca18075d8a5dcaefd647e0446b3e9620cb6336a31e3bf68897aab7d81e974a3
ISSN 0008-5472
IngestDate Fri Sep 05 08:47:34 EDT 2025
Thu Sep 04 19:38:52 EDT 2025
Wed Feb 19 01:25:54 EST 2025
Wed Apr 02 07:13:29 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Human
Urinary system disease
Nucleotide sequence
Pathogenesis
Exploration
Malignant tumor
In vitro
Tissue
Cell line
Restriction fragment length polymorphism
Urinary bladder
Mutation
Molecular biology
Onc gene
Tumor cell
Comparative study
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-h298t-d9ca18075d8a5dcaefd647e0446b3e9620cb6336a31e3bf68897aab7d81e974a3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
PMID 8093230
PQID 16576534
PQPubID 23462
PageCount 7
ParticipantIDs proquest_miscellaneous_75520985
proquest_miscellaneous_16576534
pubmed_primary_8093230
pascalfrancis_primary_4478739
PublicationCentury 1900
PublicationDate 1993
1993-Jan-01
19930101
PublicationDateYYYYMMDD 1993-01-01
PublicationDate_xml – year: 1993
  text: 1993
PublicationDecade 1990
PublicationPlace Philadelphia, PA
PublicationPlace_xml – name: Philadelphia, PA
– name: United States
PublicationTitle Cancer research (Chicago, Ill.)
PublicationTitleAlternate Cancer Res
PublicationYear 1993
Publisher American Association for Cancer Research
Publisher_xml – name: American Association for Cancer Research
SSID ssj0005105
Score 1.7250539
Snippet A series of 152 human bladder tumors, 14 bladder tumor cell lines, and 1 immortal urothelial cell line were examined by single-strand conformation polymorphism...
SourceID proquest
pubmed
pascalfrancis
SourceType Aggregation Database
Index Database
StartPage 133
SubjectTerms Base Sequence
Biological and medical sciences
cell lines
Codon - genetics
DNA, Single-Stranded - chemistry
DNA, Single-Stranded - genetics
Electrophoresis, Polyacrylamide Gel - methods
Exons - genetics
frequency
Genes, ras - genetics
H-ras gene
Ha-ras
Humans
man
Medical sciences
Molecular Sequence Data
Mutation
Neoplasm Staging
Nephrology. Urinary tract diseases
Nucleic Acid Conformation
oncogenes
Polymorphism, Genetic - genetics
Polymorphism, Restriction Fragment Length
Reproducibility of Results
restriction fragment length polymorphism
sequence
Sequence Analysis, DNA - methods
single-strand conformation polymorphism
Tumors of the urinary system
tumours
urinary bladder
Urinary Bladder Neoplasms - genetics
Urinary Bladder Neoplasms - pathology
Urinary tract. Prostate gland
Title Mutation of H-ras is infrequent in bladder cancer : confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing
URI https://www.ncbi.nlm.nih.gov/pubmed/8093230
https://www.proquest.com/docview/16576534
https://www.proquest.com/docview/75520985
Volume 53
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELaqPSAuiAVWFFjwgRukqus8HG4ILapY2hXSrthbZTsOXamkKE0Pu7-J_8BfY8aPPBArHlIVRVHsWJqvtmf8zTeEvCy0yrOZiiOmRRrFUvBIlppHShhc72CR4ZiNvFim84v4w2VyORp977GW9o2a6Jvf5pX8j1XhGdgVs2T_wbJtp_AA7sG-cAULw_WvbLzYN-2Obx7VcoflyaHj2vKjrfi_2uDUUiO5S3vVCPCAyyufsoi7T4wWbEyEMQ-b41a1CY1YwuH66xZM4UppOP0StEphiR8GU1-w8IerN17W8ovlFmB1lmY9aL0LNFG3hr7yFO6wcHZaCThKr0C0tkfMjiti57LNZtKLXJwuzz5_PLHUw8Wki8mG-MTZsgv2Fj7Pj3cQDCdVPXxayqUfQmAkDmZ1ESVxNpjVnQTxAL1uimZOeMOv9sxJKQ2FuH9ZIFvaYoxKRhyzRWFbh_zB00-dNH3i-bJhMMiylTv4o5WuQsrtLozdypzfJ_e8D0LfOkAdkpGpHpA7C8-yeEh-BFzRbUktrugV_FpcwS31uKIOV_QN7aOKqms6QBXto4r2cUEDql7TgCnawxQNmKIOU4O20Ab7doiiHaIekYv3J-fv5pEv9BGtZ7looiLXkqEqdiFkUmhpyiKNM4NcA8VNns6mWqWcp5Izw1WZCpFnUqqsEMyAPyz5ETmotpV5TKhiSnB4PZ4aDZ5CKaazUqfGZCwvcibSMTkeWGX1zYm6rLxtx-RFsNIKJlo8PZOV2e53K5aCa57w-PY3sgQ5ZSIZkyNn3rZzMQU3iU-f_OHjT8ldx6fFCN8zctDUe3MMe95GPbdY-wlu77-r
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mutation+of+H-ras+is+infrequent+in+bladder+cancer+%3A+confirmation+by+single-strand+conformation+polymorphism+analysis%2C+designed+restriction+fragment+length+polymorphisms%2C+and+direct+sequencing&rft.jtitle=Cancer+research+%28Chicago%2C+Ill.%29&rft.au=KNOWLES%2C+M.+A&rft.au=WILLIAMSON%2C+M&rft.date=1993&rft.pub=American+Association+for+Cancer+Research&rft.issn=0008-5472&rft.volume=53&rft.issue=1&rft.spage=133&rft.epage=139&rft.externalDBID=n%2Fa&rft.externalDocID=4478739
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-5472&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-5472&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-5472&client=summon